Cardiac Biomarkers describes the most recent developments in the field of biomarkers, providing best practice and current guidelines. It also discusses how these guidelines may alter in the future. With contributions from internationally-based clinicians and scientists, this book includes almost 100 detailed images and illustrations. Topics covered include: Markers of Cardiac Arrest, Markers of Cardiac Ischemia, Natriuretic Peptides for Heart Failure, Biomarkers in Cardio Renal Disease and Future Developments.
Salient Features * This book provides focused and relevant information to guide clinicians on today's best practices. Also alerts them as to what might be available in the near future. * Updates on current guidelines, as well as suggests how guidelines might be altered in the coming times. * Offers a clear vision of the exciting developments in the field of cardiac biomarkers. * State-of-the-art topics on markers that are in use currently along with the up and coming biomarkers. * Offers a clear vision of the exciting developments in the field of cardiac biomarkers.
Table of Contents Section 1: Markers of Cardiac Risk * Overview of Markers of Cardiac Risk * OxPL/apoB Containing Lipoproteins: A Biomarker Predicting Cardiovascular Disease and Events
Section 2: Markers of Cardiac Ischemia * Diagnosis and Risk Stratification of Acute Coronary Syndrome * Laboratory Perspective on Biomarkers for Acute Coronary * Hypersensitive * Evolving Biomarkers for Cardiac Ischemia
Section 3: Natriuretic Peptides for Heart Failure * Natriuretic Peptides in Patients with Acute Shortness of Breath * Natriuretic Peptides in the Hospital: Risk Stratification and Treatment Titration * Natriuretic Peptides in the Outpatient Setting
Section 4: Biomarkers in Cardio Renal Disease * Cardio renal Syndromes * Assessing Kidney Injury in Heart Failure: The Role of Biomarkers
Section 5: Looking towards the Future * Adrenomedullin * Galectin-3 * ST2 * Copeptin * Index